UTROL Capsules

INDICATIONS:

1: ANAEMIA
2: LEUORRHOEA
3: MENORRHAGIA
4: GENERAL DEBILITY
5: HABITUAL ABORTION
6: NON SPECIFIC VAGINITIS
7 : MALE & FEMALE INFERTILITY
COMPOSITION: 

Constituents
Faulad
Momiai
Oyster Shell
Gum Acacia
Butea Frondosa
Emblica Officinalis
Cinnamomum Cassia
Elettaria Cardamomum

Active Ingredients
Iron (Herbal Processed)
Benzoates, Mminerals, Icthyol
Calcium
Arabic Acid
Glucosides
Vitamin-C, Minerals
Cinnamic acid, Volatile oil
Terpinyl acetate
DESCRIPTION:
Utrol is a specified combination of natural astringents, anti spasmadics and anti microbials so check leucorrhoes, non-specific vaginitis and menorrhagia. Cardamomum in Utrol, a source of terpinyl acetate nausea, vomiting, headache and acts as a refrigerant.
Utrol contaions herbal processed iron, Emblica - the richest source anaemia, general debility and calcium Deficiency
Regular use of Utrol restores normal function of the uterus, imparts vigour to the uterine system and thus minimizes the chances of habitual abortion. The role of Utrol as a supportive therapy is highly appreciable in female infertility provided this infertility is not due to surgical indications. Like wise the role of Utrol as a supportive therapy in male infertility is also considerable where it helps in increasing the percentage of alive sperms and their motility.

Side Effects:
Very few number of patients may suffer mild constipation that can be relieved with the use of milk or excessive quantity of water.

Dosage:
In leucorrhoea, non-specific vaginitis and menorrhagia one capsule of Utrol B.D (twice a day) with milk for one month. In anaemia and general debility one capsule of Utrol O.D (once daily) with milk for one month.
In habitual abortion, male & female infertility one capsule of Utrol B.D (Twice a day) for 3 months as a supportive therapy. In pregnancy one capsule of Utrol O.D (one daily) throughout pregnancy.

Packing:
One pack of 20's capsules.

Contact us
+923451696400
myfirstwab0@gmail.com

         ABAPEN 100mg Capsules

Zolanix

(Fluconazole) 150 mg Capsule

COMPOSITION: each capsule contains 150 mg of fluconazole.

INDICATIONS:

ZOLANIX is indicated in adults for the treatment of the following fungal infection:
Cryptococcal meningitis, coccidioidomycosis, invasive candidiasis, mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis, chronic oral atrophic candidiasis if dental hygiene or topical treatment are insufficient, (vaginal candidiasis, acute or recurrent and candidal balanitis (when local therapy is not appropriate)), dermatomycosis including  tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated and tinea unguinium when other agents are not considered appropriate.
Also for prophylaxis of relapse of: cryptococcal meningitis, oroharyngeal or oesophageal candidiasis, recurrent vaginal candidiasis and candidal infection in patients with prolonged neutropenia.

DOSAGE AND ADMINISTRATION
Adults and adolescents: Cryptococcosis: 4 mg on day 1, subsequent dose: 200 mg to 400 mg daily. Inv asive candidiasi: 800 mg on day 1, subsequent dose: 400 mg daliy. coccidioidomycosis, treatment of mucosal candidiasis and prophylaxis of candidal infections in patintes with prolonged neutropenia: 200 mg to 400 mg. prevention of relapse of mucosal candidiasis in patients in fected with or risk of HIV: 100 mg 200 mg daily. genital candidiasis 150 mg as single dose. dermantomycosis: 150 mg once weekly.

CONTRACTIONS: Hypersensitivy to the active substance, or to of the excipients coadministration of other medicinal products known to prolong the QT interval and which are metabolised via the cytochrome P450 (CYO) 3AA such as cisapride, astemizole, pimozide, quinidine and erythromycin. coadministration of terfenadine is contraindicated in patients receiving fluconazole at multiple doses of 400 mg per day or higher.

Pregnancy and Lactation: Fluconazole in high dose and/or in prolonged regimens should not be used during pregnancy except for potentially life-threatening infections. An observational study has suggested an increased risk of spontaneous abortion in woman treated with fluconazole during the first trimester. Breast-feeding is not recommended after repeated use or after high dose fluconazole.

OVERDOSAGE
Hallucinatin and paranoid behaviour have been concmitantly reported. In the event of overdose, symptomatic treatment (with supportive measures) may be adequate. A three-hour haemodialysis session decreases plasma level by approximately 50%. Further management should be as clinically indicated or as recommended by the national poisons canter, where available.